ZOULIM , Fabien

Last name: ZOULIM

First name: Fabien

May 26, 2023 (v1)

Publication

Metadata-only

Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study

Roche, Bruno Bauhofer, Artur Gómez Bravo, Miguel Ángel

Background: Self-administered subcutaneous hepatitis B immunoglobulin (s.c. HBIg) in combination with nucleos(t)ide analogs (NUCs) has proved to be effective and safe in preventing hepatitis B virus (HBV) reinfection after liver transplantation. Material and methods: This non-interventional, prospective, single-arm, multicenter, international...

Uploaded on: May 27, 2023
June 2004 (v1)

Journal article

Metadata-only

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

Werle-Lapostolle, Bettina Bowden, Scott Locarnini, Stephen

BACKGROUND & AIMS: Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is a unique episomal replicative intermediate responsible for persistent infection of hepatocytes. Technical constraints have hampered the direct study of cccDNA maintenance and clearance mechanisms in patients. The aim of this study was to develop a sensitive...

Uploaded on: March 26, 2023
2020 (v1)

Journal article

Metadata-only

Sofosbuvir-Daclatasvir Is Suboptimal in Patients with Genotype 2 Chronic Hepatitis C Infection: Real-life Experience from the HEPATHER ANRS CO22 Cohort

Lédinghen, Victor Lusivika-Nzinga, Clovis Bronowicki, Jean-Pierre

International audience

Uploaded on: December 3, 2022
2017 (v1)

Journal article

Metadata-only

Retreatment with sofosbuvir plus grazoprevir plus elbasvir plus ribavirin of patients with Hepatitis C virus Genotype 1 or 4 with RASs at failure of a sofosbuvir plus ledipasvir or plus daclatasvir or plus simeprevir regimen (ANRS HC34 REVENGE study)

Ledinghen, Victor Laforest, Claire Hézode, Christophe

67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) - Boston, MA - 2016-11-11

Uploaded on: February 28, 2023
March 19, 2018 (v1)

Journal article

Metadata-only

Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study

de Ledinghen, Victor Laforest, Claire Hezode, Christophe

Background: Failure to achieve sustained virological response (SVR) with hepatitis C virus (HCV) direct-acting antiviral (DAA)–based regimens is commonly associated with emergence of resistance-associated substitutions (RASs). Retreatment of patients who failed prior DAAs remains challenging. The aim of this prospective and randomized study was...

Uploaded on: February 27, 2023

ZOULIM , Fabien

Recent uploads